The agency also expanded approval of a recombinant von Willebrand factor product (Vonvendi) to include routine prophylaxis in ...

Human papilloma virus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer caused by the virus, with rates increasing each year.

Human papillomavirus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer ...

Researchers hope the advanced warning could enable earlier, less invasive treatments with fewer side effects and better outcomes.

Researchers from the German Cancer Research Center (DKFZ) have collaborated with the SILVACX project group at Heidelberg ...

The HPV vaccine has led to an 80 percent decrease in cervical precancer cases among young women, showing its effectiveness in ...

Imagine your skin as a bustling city. Each cell is a hardworking citizen, repairing sun damage and keeping the peace. But lurking in the shadows is a virus long thought to be a harmless drifter: ...

Imagine if there were a vaccine for breast cancer, lung cancer, prostate cancer, uterine cancer, ovarian cancer or any of the most well-known cancers that sicken and kill so many people. Every year, ...

People in some U.S. states are more likely to be diagnosed with HPV-associated cancers than in others—with this discrepancy likely linked to awareness of the risk from the virus. Overall, one in three ...